Pennsylvania Act 2014-148 — NEWBORN CHILD TESTING ACT - NEWBORN CHILD SCREENING AND FOLLOW-UP PROGRAM

Act text

Session of 2014

No. 2014-148

HB 1654

AN ACT

Amending the act of September 9, 1965 (P.L.497, No.251), entitled, as amended, "An act requiring physicians, hospitals and other institutions to administer or cause to be administered tests for genetic diseases upon infants in certain cases," further providing for newborn child screening and follow-up program.

The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:

Section 1. Section 3(a)(1) of the act of September 9, 1965 (P.L.497, No.251), known as the Newborn Child Testing Act, amended July 4, 2008 (P.L.288, No.36), is amended to read:

Section 3. Newborn Child Screening and Follow-up Program.--(a) In order to assist health care providers to determine whether treatment or other services are necessary to avert mental retardation, permanent disabilities or death, the department, with the approval of the Newborn Screening and Follow-up Technical Advisory Committee, shall establish a program providing for:

(1) The screening tests of newborn children for the following diseases:

(i) Phenylketonuria (PKU).

(ii) Maple syrup urine disease (MSUD).

(iii) Sickle-cell disease (hemoglobinopathies).

(iv) Galactosemia.

(v) Congenital adrenal hyperplasia (CAH).

(vi) Primary congenital hypothyroidism.

(vii) Certain Lysosomal storage disorders (LSDs), including:

(A) Globoid Cell Leukodystrophy (Krabbe).

(B) Fabry.

(C) Pompe.

(D) Niemann-Pick.

(E) Gaucher.

(F) Hurler Syndrome (MPS I).

---

Section 2. This act shall take effect in 60 days.

APPROVED--The 15th day of October, A.D. 2014.

TOM CORBETT